Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifaximin vs Placebo for the Prevention of Encephalopathy in Patients Treated by TIPS
NCT02016196Phase 3Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Sep 2013
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rifaximin in hepatic encephalopathy (HE), sponsored by Centre hospitalier universitaire de Toulouse. Started Sep 2013; status: completed.
02
Drugs
rifaximin
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT02016196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02016196.